EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model

Alexandra E Johns iD, Arens Taga iD, Andriana Charalampopoulou iD, Sarah K Gross iD, Khalil Rust iD, Brett A McCray iD, Jeremy M Sullivan iD, Nicholas J Maragakis iD

Stem Cells Translational Medicine · 2024

DOI: 10.1093/stcltm/szae074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2024. Verfasst von Alexandra E Johns und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States. Hauptthemen laut MEDLINE: Motor Neurons, Receptors, Purinergic P2X7, Induced Pluripotent Stem Cells, Purinergic P2X Receptor Antagonists. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ATP is present in negligible concentrations in the interstitium of healthy tissues but accumulates to significantly higher concentrations in an inflammatory microenvironment. ATP binds to 2 categories of purine receptors on the surface of cells, the ionotropic P2X receptors and metabotropic P2Y receptors. Included in the family of ionotropic purine receptors is P2X7 (P2X7R), a non-specific cation channel with unique functional and structural properties that suggest it has distinct roles in pathological conditions marked by increased extracellular ATP. The role of P2X7R has previously been explored in microglia and astrocytes within the context of neuroinflammation, however the presence of P2X7R on human motor neurons and its potential role in neurodegenerative diseases has not been the focus of the current literature. We leveraged the use of human iPSC-derived spinal motor neurons (hiPSC-MN) as well as human and rodent tissue to demonstrate the expression of P2X7R on motor neurons. We extend this observation to demonstrate that these receptors are functionally active on hiPSC-MN and that ATP can directly induce death via P2X7R activation in a dose dependent manner. Finally, using a highly specific P2X7R blocker, we demonstrate how modulation of P2X7R activation on motor neurons is neuroprotective and could provide a unique pharmacologic target for ATP-induced MN death that is distinct from the role of ATP as a modulator of neuroinflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Motor NeuronsReceptors, Purinergic P2X7Induced Pluripotent Stem CellsPurinergic P2X Receptor AntagonistsHumansAnimalsAdenosine TriphosphateNeuroprotectionMiceRats

Stichwörter der Autor:innen

ALSATPP2X7hiPSCpurinergic signaling

Substanzen

Receptors, Purinergic P2X7Purinergic P2X Receptor AntagonistsAdenosine TriphosphateP2RX7 protein, human

Autor:innen und Institutionen

  • Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States.

ORCID-Profile: Alexandra E Johns, Arens Taga, Andriana Charalampopoulou, Sarah K Gross, Khalil Rust, Brett A McCray, Jeremy M Sullivan, Nicholas J Maragakis

Förderung

  • NINDS NIH HHS

Zitieren

APA

Johns, A. E., Taga, A., Charalampopoulou, A., Gross, S. K., Rust, K., McCray, B. A., Sullivan, J. M., & Maragakis, N. J. (2024). Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szae074

Vancouver

Johns AE, Taga A, Charalampopoulou A, Gross SK, Rust K, McCray BA, et al. Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model. Stem Cells Translational Medicine. 2024. doi:10.1093/stcltm/szae074

BibTeX
@article{Johns2024,
  author = {Johns, Alexandra E and Taga, Arens and Charalampopoulou, Andriana and Gross, Sarah K and Rust, Khalil and McCray, Brett A and Sullivan, Jeremy M and Maragakis, Nicholas J},
  title = {Exploring P2X7 receptor antagonism as a therapeutic target for neuroprotection in an hiPSC motor neuron model},
  journal = {Stem Cells Translational Medicine},
  year = {2024},
  doi = {10.1093/stcltm/szae074}
}
Kostenlos starten →